The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

PHASE4RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2029

Conditions
Solid Tumors
Interventions
DRUG

Binimetinib only treatment

Binimetinib will be administered at the same dose level (15 mg to 45 mg) as that received in the Parent Studies C4211001 and C4211003 with water irrespective of food, continuously, starting on Day 1.

DRUG

Encorafenib only Treatment

Encorafenib will be self-administered at the same dose level as that received in the C4221010 Parent Study.

DRUG

Encorafenib & Binimetinib Treatment

Encorafenib will be administered on a 300 mg QD schedule and binimetinib will be administered on a 45 mg BID schedule, both orally as a flat fixed dose. Cetuximab will be administered at either 400 mg/m2 or 500 mg/m2 IV every 2 weeks on Days 1 and 15 of every cycle.

DRUG

Treatment of Encorafenib & Binimetinib & Ribociclib

Encorafenib capsule and ribociclib capsules or tablets will be co-administered orally QD with binimetinib tablets BID. The study drugs will be administered as a flat-fixed dose, and not by body weight or body surface area.

DRUG

Treatment of Encorafenib & Binimetinib & Cetuximab

Encorafenib will be administered on a 300 mg QD schedule and binimetinib will be administered on a 45 mg BID schedule, both orally as a flat fixed dose. Cetuximab will be administered at either 400 mg/m2 or 500 mg/m2 IV every 2 weeks on Days 1 and 15 of every cycle.

Trial Locations (63)

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

4032

RECRUITING

Debreceni Egyetem Klinikai Kozpont, Debrecen

10022

RECRUITING

Rockefeller Outpatient Pavilion (53rd Street), New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10117

RECRUITING

Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin

12808

RECRUITING

Vseobecna fakultni nemocnice v Praze, Prague

15006

RECRUITING

CHUAC-Hospital Teresa Herrera, A Coruña

20141

ACTIVE_NOT_RECRUITING

Istituto Europeo di Oncologia IRCCS, Milan

25198

RECRUITING

Hospital Universitario Arnau de Vilanova de Lleida, Lleida

28050

RECRUITING

Hospital Universitario HM Sanchinarro, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

29011

RECRUITING

H.R.U Málaga - Hospital General, Málaga

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

30322

RECRUITING

Emory University Hospital, Atlanta

RECRUITING

Investigational Drug Service Emory University Clinic, Atlanta

RECRUITING

Winship Cancer Institute of Emory University, Atlanta

33011

RECRUITING

Hospital Universitario Central de Asturias, Oviedo

39120

ACTIVE_NOT_RECRUITING

Otto-von-Guericke-Universitat Magdeburg, Magdeburg

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna

55101

RECRUITING

HealthPartners Cancer Research Center, Saint Paul

RECRUITING

Regions Hospital Pharmacy, Saint Paul

55130

RECRUITING

HealthPartners Specialty Center, Saint Paul

59037

ACTIVE_NOT_RECRUITING

Hopital Claude Huriez - CHU de Lille, Lille

63108

RECRUITING

Siteman Cancer Center, St Louis

63110

RECRUITING

Barnes-Jewish Hospital, St Louis

RECRUITING

Washington University School of Medicine, St Louis

70124

RECRUITING

Instituto Tumori Giovanni Paolo II, Bari

72076

ACTIVE_NOT_RECRUITING

Universitaetsklinikum Tuebingen, Tübingen

80131

RECRUITING

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli

85004

RECRUITING

St. Joseph's Hospital and Medical Center, Phoenix

85013

RECRUITING

St. Joseph's Hospital and Medical Center, Phoenix

94800

ACTIVE_NOT_RECRUITING

Gustave Roussy, Villejuif

115478

RECRUITING

"Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF", Moscow

197758

RECRUITING

N.N.Petrov Research Institute of Oncology, Saint Petersburg

RECRUITING

N.N.Petrov Research Institute of Oncology, Saint Petersburg

3109601

RECRUITING

Rambam Health Care Campus, Haifa

14784400

RECRUITING

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos

02114

RECRUITING

Massachusetts General Hospital, Boston

07920

RECRUITING

MSK Basking Ridge, Basking Ridge

59062-000

RECRUITING

Liga Norte Riograndense Contra o Câncer, Natal

98700-000

RECRUITING

ONCOSITE - Centro de Pesquisa Clinica em Oncologia, Ijuí

01321-001

RECRUITING

BP - A Beneficencia Portuguesa de São Paulo, São Paulo

01323-030

RECRUITING

Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

04032

RECRUITING

Debreceni Egyetem Klinikai Kozpont, Debrecen

00144

RECRUITING

Istituto Nazionale Tumori Regina Elena, Rome

6525 GA

RECRUITING

Radboudumc, Nijmegen

1066 CX

RECRUITING

Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam

RECRUITING

Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam

8025 AB

ACTIVE_NOT_RECRUITING

Isala, locatie Zwolle, Zwolle

1099-023

RECRUITING

Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon

4200-072

RECRUITING

Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto

833 10

ACTIVE_NOT_RECRUITING

Narodny onkologicky ustav, Bratislava

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

06351

RECRUITING

Samsung Medical Center, Seoul

08916

RECRUITING

Institut Català d'Oncologia (ICO) - Badalona, Badalona

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

08008

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08036

RECRUITING

Hospital Clínic de Barcelona, Barcelona

PR2 9HT

RECRUITING

Lancashire Teaching Hospitals NHS Foundation Trust - Royal Preston Hospital, Preston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY